弘信電子(300657.SZ):第二期員工持股計劃鎖定期屆滿
格隆匯1月12日丨弘信電子(300657.SZ)公佈,公司第二期員工持股計劃鎖定期將於2022年1月12日屆滿。
2021年7月13日,公司實施了2020年度權益分配事宜,以扣除回購專用賬户上的總股本339,217,281股為基數,以資本公積向全體股東每10股轉增2股。轉增後本期員工持股計劃持股總數變更為979.9448萬股,佔權益分配完成時公司總股本比例2.39%(權益分配完成時公司總股本409,581,951股),佔當前公司總股本的比例2.20%(公司當前總股本445,053,082股)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.